Cargando…

Identification of 5 Gene Signatures in Survival Prediction for Patients with Lung Squamous Cell Carcinoma Based on Integrated Multiomics Data Analysis

BACKGROUND: Lung squamous cell carcinoma (LSCC) is a frequently diagnosed cancer worldwide, and it has a poor prognosis. The current study is aimed at developing the prediction of LSCC prognosis by integrating multiomics data including transcriptome, copy number variation data, and mutation data ana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Hongxia, Tong, Lihong, Zhang, Qian, Chang, Wenjun, Li, Fengsen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298313/ https://www.ncbi.nlm.nih.gov/pubmed/32596344 http://dx.doi.org/10.1155/2020/6427483

Ejemplares similares

Identification of Survival-Associated Alternative Splicing Signatures in Lung Squamous Cell Carcinoma
por: Liu, Yang, et al.
Publicado: (2020)

Identification and Validation of a Novel Multiomics Signature for Prognosis and Immunotherapy Response of Endometrial Carcinoma
por: Wu, Zhicheng, et al.
Publicado: (2022)

Identification and Validation of Prognostic Markers for Lung Squamous Cell Carcinoma Associated with Chronic Obstructive Pulmonary Disease
por: Li, Zheng, et al.
Publicado: (2022)

Identification and Validation of Three-Gene Signature in Lung Squamous Cell Carcinoma by Integrated Transcriptome and Methylation Analysis
por: Li, Guanghua, et al.
Publicado: (2022)

Identification and Validation of a Four-Gene Ferroptosis Signature for Predicting Overall Survival of Lung Squamous Cell Carcinoma
por: Wang, Qi, et al.
Publicado: (2022)

Integrated multiomic approach for identification of novel immunotherapeutic targets in AML
por: Köhnke, Thomas, et al.
Publicado: (2022)

An Integrative Multiomics Framework for Identification of Therapeutic Targets in Pulmonary Fibrosis
por: Arif, Muhammad, et al.
Publicado: (2023)

Identification of seven-gene signature for prediction of lung squamous cell carcinoma
por: Wang, Zhe, et al.
Publicado: (2019)

Multiomics Integrative Analysis Identifying EPC1 as a Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma
por: Dai, Yongmei, et al.
Publicado: (2022)

Embracing Integrative Multiomics Approaches
por: Rotroff, Daniel M., et al.
Publicado: (2016)

Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
por: Li, Na, et al.
Publicado: (2021)

Identification of a microRNA signature associated with survivability in cervical squamous cell carcinoma
por: Ma, Chengbin, et al.
Publicado: (2018)

Identification and validation of a glycolysis-associated multiomics prognostic model for hepatocellular carcinoma
por: Deng, Tuo, et al.
Publicado: (2021)

Multiomics Immune-Related lncRNA Analysis of Oral Squamous Cell Carcinoma and Its Correlation with Prognosis
por: Liu, Zhen, et al.
Publicado: (2022)

Identification of an immune classification for cervical cancer and integrative analysis of multiomics data
por: Lyu, Xintong, et al.
Publicado: (2021)

Multiomics Differences in Lung Squamous Cell Carcinoma Patients with High Radiosensitivity Index Compared with Those with Low Radiosensitivity Index
por: Du, Yajing, et al.
Publicado: (2021)

Identification of prognostically relevant gene signatures in lung squamous cell carcinoma by Lung Cancer Explorer
por: Wang, Yuqing, et al.
Publicado: (2021)

Multiomics signatures of type 1 diabetes with and without albuminuria
por: Clos-Garcia, Marc, et al.
Publicado: (2022)

Identification of a two metastasis-related prognostic signature in the process of predicting the survival of laryngeal squamous cell carcinoma
por: Zheng, Yuebin, et al.
Publicado: (2023)

Mutational signatures in squamous cell carcinoma of the lung
por: Osoegawa, Atsushi, et al.
Publicado: (2021)

Identification of a new anoikis-related gene signature for prognostic significance in head and neck squamous carcinomas
por: Wei, Zhengyu, et al.
Publicado: (2023)

Integrative multiomics evaluation reveals the importance of pseudouridine synthases in hepatocellular carcinoma
por: Jin, Zhipeng, et al.
Publicado: (2022)

Identification of a Novel Signature Predicting Overall Survival in Head and Neck Squamous Cell Carcinoma
por: Zheng, Haige, et al.
Publicado: (2021)

Identification of an Immune Gene Expression Signature for Predicting Lung Squamous Cell Carcinoma Prognosis
por: Yan, Yubo, et al.
Publicado: (2020)

Identification of miRNA signature for predicting the prognostic biomarker of squamous cell lung carcinoma
por: Liu, Huanqing, et al.
Publicado: (2022)

Identification of Cancer Driver Genes by Integrating Multiomics Data with Graph Neural Networks
por: Song, Hongzhi, et al.
Publicado: (2023)

A multiomic ferroptosis-associated prognostic signature incorporating epigenetic and transcriptional biomarkers for hepatocellular carcinoma
por: Chen, Jida, et al.
Publicado: (2022)

Multiomic Investigations into Lung Health and Disease
por: Blutt, Sarah E., et al.
Publicado: (2023)

Identification of Immune Subtypes of Lung Squamous Cell Carcinoma by Integrative Genome-Scale Analysis
por: Yin, Liyuan, et al.
Publicado: (2022)

Screening and Identification of Survival-Associated Splicing Factors in Lung Squamous Cell Carcinoma
por: Chen, Min, et al.
Publicado: (2022)

Integrative Analysis of Pyroptosis-Related Prognostic Signature and Immunological Infiltration in Lung Squamous Cell Carcinoma
por: Luo, Pengfei, et al.
Publicado: (2022)

Identification of a Prognostic Immune Signature for Esophageal Squamous Cell Carcinoma to Predict Survival and Inflammatory Landscapes
por: Zhang, Chaoqi, et al.
Publicado: (2020)

Multiomic Integration of Public Oncology Databases in Bioconductor
por: Ramos, Marcel, et al.
Publicado: (2020)

Executable Network Models of Integrated Multiomics Data
por: Palshikar, Mukta G., et al.
Publicado: (2023)

Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma
por: Gao, Xujie, et al.
Publicado: (2016)

Identification of an Innate Immune-Related Prognostic Signature in Early-Stage Lung Squamous Cell Carcinoma
por: Li, Liang, et al.
Publicado: (2021)

Survival-associated N(6)-adenosine methyltransferase signatures in lung squamous cell carcinoma and clinical verification
por: Qu, Jialin, et al.
Publicado: (2021)

A glycolysis-based three-gene signature predicts survival in patients with lung squamous cell carcinoma
por: Huang, Guichuan, et al.
Publicado: (2021)

Ferroptosis-related lncRNAs signature to predict the survival and immune evasion for lung squamous cell carcinoma
por: Zhang, Rusi, et al.
Publicado: (2022)

Patient subgrouping with distinct survival rates via integration of multiomics data on a Grassmann manifold
por: Alfatemi, Ali, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rr6o9l31hsnmnehi1n4595cnld